These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 17603264)
1. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents]. Morita M Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264 [TBL] [Abstract][Full Text] [Related]
2. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations]. Takahashi N; Morita M; Imanaka T Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797 [TBL] [Abstract][Full Text] [Related]
3. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276 [TBL] [Abstract][Full Text] [Related]
4. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471 [TBL] [Abstract][Full Text] [Related]
5. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice. Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441 [TBL] [Abstract][Full Text] [Related]
6. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332 [TBL] [Abstract][Full Text] [Related]
7. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. Singh J; Khan M; Singh I J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797 [TBL] [Abstract][Full Text] [Related]
9. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Heinzer AK; Watkins PA; Lu JF; Kemp S; Moser AB; Li YY; Mihalik S; Powers JM; Smith KD Hum Mol Genet; 2003 May; 12(10):1145-54. PubMed ID: 12719378 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy. Unterrainer G; Molzer B; Forss-Petter S; Berger J Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. McGuinness MC; Zhang HP; Smith KD Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822 [TBL] [Abstract][Full Text] [Related]
12. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. Baarine M; Beeson C; Singh A; Singh I J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703 [TBL] [Abstract][Full Text] [Related]
13. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. Ofman R; Dijkstra IM; van Roermund CW; Burger N; Turkenburg M; van Cruchten A; van Engen CE; Wanders RJ; Kemp S EMBO Mol Med; 2010 Mar; 2(3):90-7. PubMed ID: 20166112 [TBL] [Abstract][Full Text] [Related]